![Natalie Grover, MD, and Barbara Savoldo, MD](https://unclineberger.org/wp-content/uploads/sites/867/2019/01/Natalie-Grover-and-Barbara-Savoldo-600x400.jpg)
December 3, 2018
Study shows promise for fighting relapsed blood cancer with CAR-T immunotherapy, chemotherapy
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.